|
Volumn 14, Issue 2, 2007, Pages 113-122
|
Optimizing the antihormonal treatment and prevention of breast cancer.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AROMATASE INHIBITOR;
ESTROGEN RECEPTOR;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BREAST TUMOR;
CEREBROVASCULAR ACCIDENT;
CHEMICALLY INDUCED DISORDER;
DRUG RESISTANCE;
ENDOMETRIUM TUMOR;
FEMALE;
HUMAN;
METABOLISM;
NEOPLASM;
REVIEW;
VEIN THROMBOSIS;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CEREBROVASCULAR ACCIDENT;
DRUG RESISTANCE, NEOPLASM;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
NEOPLASMS, HORMONE-DEPENDENT;
RECEPTORS, ESTROGEN;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
VENOUS THROMBOSIS;
|
EID: 34748827491
PISSN: 13406868
EISSN: None
Source Type: Journal
DOI: 10.2325/jbcs.966 Document Type: Review |
Times cited : (25)
|
References (58)
|